Forget Moderna! These 2 Stocks May be the Biggest Winners of the Vaccine Race
Since the beginning of the coronavirus vaccine race, we've been hearing a lot about Moderna (NASDAQ: MRNA). That's because back in March, the biotech company became the first to launch a vaccine candidate in human trials. Now, the company is awaiting the U.S. Food and Drug Administration's (FDA) decision on its request for Emergency Use Authorization (EUA). The FDA has set its meeting to discuss Moderna's data and EUA request for Dec. 17.
This speed to market, however, doesn't necessarily mean Moderna will be the winner of the race. Other companies may enter the market later -- but with a product that eventually may become more successful. Here are two companies that are in exactly that situation today.
Image source: Getty Images.
Source Fool.com
